GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Redx Pharma PLC (FRA:0RX) » Definitions » Issuance of Stock

Redx Pharma (FRA:0RX) Issuance of Stock : €0.00 Mil (TTM As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Redx Pharma Issuance of Stock?

Redx Pharma's Issuance of Stock for the six months ended in Sep. 2023 was €0.00 Mil.

Redx Pharma's Issuance of Stock for the trailing twelve months (TTM) ended in Sep. 2023 was €0.00 Mil.

Redx Pharma Issuance of Stock Historical Data

The historical data trend for Redx Pharma's Issuance of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Redx Pharma Issuance of Stock Chart

Redx Pharma Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Issuance of Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 2.31 30.33 39.54 -

Redx Pharma Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Issuance of Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.37 - - - -

Redx Pharma Issuance of Stock Calculation

A company may raise cash from issuing new shares. Issuance of Stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Issuance of Stock for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Redx Pharma Issuance of Stock Related Terms

Thank you for viewing the detailed overview of Redx Pharma's Issuance of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Redx Pharma (FRA:0RX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Redx Pharma PLC (FRA:0RX) » Definitions » Issuance of Stock
Comparable Companies
LSE:FUM LSE:OBD LSE:SCLP LSE:4BB LSE:ETX LSE:AREC LSE:SBTX LSE:DEST LSE:SAR LSE:HVO OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
REDX:UK
Address
Block 33, Mereside, Alderley Park, Macclesfield, GBR, SK10 4TG
Website
https://www.redxpharma.com
Redx Pharma PLC is a United Kingdom-based biotechnology company focused on the development of novel precision medicines that have the potential to transform treatment in oncology and fibrotic diseases. Its product pipeline under development includes Porcupine Inhibitor, ROCK2 Selective Inhibitor, GI-targeted ROCK inhibitor, Pan-RAF Inhibitor, and others. The firm operates geographically in UK and Ireland. Revenue is generated from; Scientific programmes and research collaboration, Research collaboration and Research and preclinical development services. Redx is a clinical-stage biotechnology company focused on the discovery & development of novel, small-molecule, targeted medicines for the treatment of cancer and fibrotic disease and the emerging area of cancer-associated fibrosis.

Redx Pharma (FRA:0RX) Headlines

No Headlines